12:00 AM
Dec 07, 2009
 |  BC Week In Review  |  Clinical News  |  Clinical Status

DV-601: Completed Phase Ib enrollment

Dynavax completed enrollment of up to 6 patients in the first of 3 cohorts in an open-label, dose-escalation, Polish Phase Ib trial...

Read the full 87 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >